Neoadjuvant SHR-1701 with or Without Chemotherapy in Unresectable Stage III Non-Small-cell Lung Cancer: A Proof-of-concept, Phase 2 Trial
CANCER CELL(2024)
Key words
stage III NSCLC,unresectable NSCLC,surgical conversion,neoadjuvant immunotherapy,bispecific antibody,TGF-beta,PD-L1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined